Ifenprodil attenuates the loss of parietal cortical parvalbumin immunoreactivity after focal cerebral ischemia in the mouse.
O'Mahony
S
S
Department of Pharmacology, University College Galway, Ireland.
Noonan
D
D
Harkány
T
T
De Jong
G I
GI
Nyakas
C
C
Leonard
B E
BE
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000378:metabolism; D002536:Cerebral Arteries / Q000187:drug effects / Q000378:metabolism; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D007150:Immunohistochemistry; D007395:Interneurons / Q000187:drug effects / Q000378:metabolism; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D051379:Mice; D010296:Parietal Lobe / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D010320:Parvalbumins / Q000378:metabolism*; D010880:Piperidines / Q000627:therapeutic use*
D018691:Excitatory Amino Acid Antagonists; D010320:Parvalbumins; D010880:Piperidines; C010739:ifenprodil